文献速递脑血管病

高敏肌钙蛋白T与轻型卒中或TIA后主要血管事件复发相关

Cardiac Troponin and Recurrent Major Vascular Events after Minor Stroke or Transient Ischemic Attack.
PubMed 文献 · Ann Neurol · 2021-10-11

本研究为INSPiRE-TMS试验的事后分析,纳入889例轻型卒中或TIA患者,探讨高敏肌钙蛋白T(hs-cTnT)与主要不良心血管事件(MACE)的关联。平均随访3.2年,153例(17.2%)发生MACE。hs-cTnT>14ng/l与MACE风险独立相关(调整HR=1.63,95%CI 1.13-2.35),且与ABCD2评分存在显著交互作用(p=0.04),在低危患者中hs-cTnT>URL者MACE年发生率9.5%,高于≤URL者的3.8%。

要点

  • hs-cTnT>14ng/l与轻型卒中或TIA后3年内MACE风险增加独立相关。
  • hs-cTnT与ABCD2评分存在交互作用,可识别ABCD2低危但实际高危的患者。
  • 对hs-cTnT升高的卒中患者,或需强化二级预防和心脏检查。

核心结论

  • hs-cTnT水平与轻型卒中或TIA后3年内MACE发生相关,可能有助于识别ABCD2评分为低危的高风险个体。

研究设计与样本

  • INSPiRE-TMS随机对照试验的事后分析,纳入889例轻型卒中或TIA患者,平均年龄70岁,37%女性。
  • 按hs-cTnT水平(第5代Roche检测,99百分位URL=14ng/l)和ABCD2评分(低危0-5 vs 高危6-7)分组。
  • 采用Cox比例风险回归进行协变量调整和倾向性评分匹配(PSM)。

主要发现

  • 平均随访3.2年,153例(17.2%)发生MACE。
  • hs-cTnT>URL者MACE年发生率为9.3%,≤URL者为4.4%,调整HR=1.63(95%CI 1.13-2.35)。
  • hs-cTnT最高四分位 vs 最低四分位调整HR=2.57(95%CI 1.35-4.97),对数转换后调整HR=2.31(95%CI 1.37-3.89)。
  • PSM后关联仍显著(调整HR=1.76,95%CI 1.14-2.72)。
  • hs-cTnT与ABCD2类别对MACE发生存在显著交互作用(pinteraction=0.04);低危患者中hs-cTnT>URL者MACE年发生率9.5%,高于≤URL者的3.8%,与高危组总体发生率相似。

关键数值与推荐

  • hs-cTnT第5代Roche检测,99百分位URL=14ng/l,高于此值定义为升高。
  • ABCD2评分低危为0-5分,高危为6-7分。
  • MACE定义为卒中/非致死性冠脉事件/血管性死亡。

临床怎么用

  • 对轻型卒中或TIA患者可检测hs-cTnT以辅助风险分层。
  • hs-cTnT升高的患者即使ABCD2评分低危,也应考虑强化二级预防和心脏诊断评估。

局限性

  • 本研究为事后分析,结果需在独立验证研究中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study was undertaken to investigate whether high-sensitivity cardiac troponin T (hs-cTnT) is associated with major adverse cardiovascular events (MACE) in patients with minor stroke or transient ischemic attack (TIA), and whether this association differs after risk stratification based on the Age, Blood Pressure, Clinical Features, Duration of Symptoms, Diabetes (ABCD2 ) score. METHODS: INSPiRE-TMS was a randomized controlled trial allocating patients with minor stroke or TIA to an intensified support program or conventional care. In this post hoc analysis, participants were categorized using hs-cTnT levels (5th generation; Roche Diagnostics, Manheim, Germany; 99th percentile upper reference limit [URL] = 14ng/l). Vascular risk was stratified using the ABCD2 score (lower risk = 0-5 vs higher risk = 6-7). Cox proportional hazard regression was performed using covariate adjustment and propensity score matching (PSM) for the association between hs-cTnT and MACE (stroke/nonfatal coronary event/vascular death). RESULTS: Among 889 patients (mean age = 70 years, 37% female), MACE occurred in 153 patients (17.2%) during a mean follow-up of 3.2 years. hs-cTnT was associated with MACE (9.3%/yr, >URL vs 4.4%/yr, ≤URL, adjusted hazard ratio [HR] = 1.63 [95% confidence interval (CI) = 1.13-2.35], adjusted HR [Q4 vs Q1 ] = 2.57 [95% CI = 1.35-4.97], adjusted HR [log-transformed] = 2.31 [95% CI = 1.37-3.89]). This association remained after PSM (adjusted HR = 1.76 [95% CI = 1.14-2.72]). There was a significant interaction between hs-cTnT and ABCD2 category for MACE occurrence (pinteraction = 0.04). In the lower risk category, MACE rate was 9.5%/yr in patients with hs-cTnT > URL, which was higher than in those ≤URL (3.8%/yr) and similar to the overall rate in the higher risk category. INTERPRETATION: hs-cTnT levels are associated with incident MACE within 3 years after minor stroke or TIA and may help to identify high-risk individuals otherwise deemed at lower risk based on the ABCD2 score. If confirmed in independent validation studies, this might warrant intensified secondary prevention measures and cardiac diagnostics in stroke patients with elevated hs-cTnT. ANN NEUROL 2021;90:901-912.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Hellwig S, Ihl T, Ganeshan R, et al. Cardiac Troponin and Recurrent Major Vascular Events after Minor Stroke or Transient Ischemic Attack. Ann Neurol. 2021. PMID: 34561890. doi:10.1002/ana.26225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。